Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Lennar, Darden Restaurants, Novavax Fall Premarket; Eli Lilly, H.B. Fuller Rise

Published 2022-09-22, 08:16 a/m
Updated 2022-09-22, 08:16 a/m
© Reuters

© Reuters

By Peter Nurse

Investing.com -- Stocks in focus in premarket trade on Thursday, September 22nd. Please refresh for updates.

  • Lennar (NYSE:LEN) stock fell 1.5% after the homebuilder reported better-than-expected third-quarter results, boosted by record high prices, but new home sales disappointed.

  • Darden Restaurants (NYSE:DRI) stock fell 3.3% after the Olive Garden owner said same-restaurant sales rose by 4.2% on the quarter, below expectations.
  • H.B. Fuller (NYSE:FUL) stock rose 2.2% after the adhesives company beat quarterly earnings expectations, citing “robust pricing actions to recover unprecedented raw material cost inflation.”

  • Accenture (NYSE:ACN) stock fell 0.3% after the IT services firm forecast first-quarter revenue below expectations, weighed down by IT spending cuts amid high inflation and impact from a stronger dollar.

  • Eli Lilly (NYSE:LLY) stock rose 1.8% after UBS upgraded its investment stance on the pharma company to ‘buy’ from ‘neutral’, citing the likely benefits of futures sales of a key weight loss drug.

  • Salesforce (NYSE:CRM) stock rose 2.5% after the cloud-based software company announced plans for a 25% operating margin by 2026, seeking to operate much more efficiently.

  • Target (NYSE:TGT) stock rose 0.2% after the big-box retailer announced plans to hire up to 100,000 seasonal workers for the holiday season and start offering festive deals earlier than ever.

  • Manchester United (NYSE:MANU) stock will be in focus after the English soccer club reported a net loss of 70.7 million pounds for the three months to June 30, a narrowing from a loss of 107.7 million pounds a year earlier.

  • Nike (NYSE:NKE) stock rose 0.7% after RBC (TSX:RY) initiated coverage of the retailer at ‘outperform’, saying the “100lb gorilla in sportswear” is set to surge almost 30%.

  • Novavax (NASDAQ:NVAX) stock fell 5.7% after JPMorgan downgraded its stance on the drug maker to 'underweight' from 'neutral'. citing reduced vaccine demand.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.